Cargando…

Alcohol as a Modifiable Risk Factor for Alzheimer’s Disease—Evidence from Experimental Studies

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive impairment and memory loss. Epidemiological evidence suggests that heavy alcohol consumption aggravates AD pathology, whereas low alcohol intake may be protective. However, these observations have been inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandrashekar, Devaraj V., Steinberg, Ross A., Han, Derick, Sumbria, Rachita K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253673/ https://www.ncbi.nlm.nih.gov/pubmed/37298443 http://dx.doi.org/10.3390/ijms24119492

Ejemplares similares

Targeting the transferrin receptor to develop erythropoietin for Alzheimer's disease
por: Sumbria, Rachita K.
Publicado: (2020)

Tumor necrosis factor α Inhibition for Alzheimer’s Disease
por: Chang, Rudy, et al.
Publicado: (2017)

Modulation of hepatic amyloid precursor protein and lipoprotein receptor-related protein 1 by chronic alcohol intake: Potential link between liver steatosis and amyloid-β
por: Garcia, Jerome, et al.
Publicado: (2022)

Comparative studies between the murine immortalized brain endothelial cell line (bEnd.3) and induced pluripotent stem cell-derived human brain endothelial cells for paracellular transport
por: Sun, Jiahong, et al.
Publicado: (2022)

Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 Mice
por: Ou, Weijun, et al.
Publicado: (2022)

The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
por: Yang, Joshua, et al.
Publicado: (2021)

Modifiable Risk Factors for Alzheimer’s Disease
por: Edwards III, George A., et al.
Publicado: (2019)

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
por: Geifman, Nophar, et al.
Publicado: (2017)

Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease
por: Luo, Jiao, et al.
Publicado: (2023)

Mid life modifiable risk factors for late life Alzheimer's disease
por: Sen, Chetana, et al.
Publicado: (2014)

Sleep Disturbance as a Potential Modifiable Risk Factor for Alzheimer’s Disease
por: Minakawa, Eiko N., et al.
Publicado: (2019)

MODIFIABLE RISK FACTORS FOR ALZHEIMER'S DISEASE: CURRENT STATUS AND OPPORTUNITIES FOR ACTION
por: Omura, John
Publicado: (2022)

Alcohol Use and the Risk of Developing Alzheimer’s Disease
por: Tyas, Suzanne L.
Publicado: (2001)

Effects of non-modifiable risk factors of Alzheimer’s disease on intracortical myelin content
por: Fernandez-Alvarez, Marina, et al.
Publicado: (2022)

Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
por: Liu, Jia-jia, et al.
Publicado: (2023)

Brain Endothelial Erythrophagocytosis and Hemoglobin Transmigration Across Brain Endothelium: Implications for Pathogenesis of Cerebral Microbleeds
por: Chang, Rudy, et al.
Publicado: (2018)

Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review
por: Yu, Chao-Chao, et al.
Publicado: (2020)

Current Alzheimer disease research highlights: evidence for novel risk factors
por: Brenowitz, Willa D., et al.
Publicado: (2021)

Modifiable Risk Factors for Alzheimer Disease and Subjective Memory Impairment across Age Groups
por: Chen, Stephen T., et al.
Publicado: (2014)

ALZHEIMER’S DISEASE RISK REDUCTION HEALTH COACHING: ALCOHOL EFFECTS
por: Zanjani, Faika, et al.
Publicado: (2022)

Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice
por: Castellanos, Demi M., et al.
Publicado: (2020)

The Effects of a Blood–Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy
por: Yang, Joshua, et al.
Publicado: (2023)

Genomic variation in educational attainment modifies Alzheimer disease risk
por: Raghavan, Neha S., et al.
Publicado: (2019)

Genetically determined low income modifies Alzheimer’s disease risk
por: Wang, Rong-Ze, et al.
Publicado: (2021)

Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study
por: Østergaard, Søren D., et al.
Publicado: (2015)

Unlocking Modifiable Risk Factors for Alzheimer’s Disease: Does the Oral Microbiome Hold Some of the Keys?
por: Loughman, Amy, et al.
Publicado: (2023)

Effects of phosphodiesterase 3A modulation on murine cerebral microhemorrhages
por: Sumbria, Rachita K., et al.
Publicado: (2017)

Factors Affecting the Tissue Damaging Consequences of Viral Infections
por: Sumbria, Deepak, et al.
Publicado: (2019)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

Disease-modifying treatments in Alzheimer’s disease
por: Edwards, Marc, et al.
Publicado: (2023)

Cellular Bioenergetics: Experimental Evidence for Alcohol-induced Adaptations
por: Simon, Liz, et al.
Publicado: (2022)

Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice
por: Sun, Jiahong, et al.
Publicado: (2019)

Erythrocyte–brain endothelial interactions induce microglial responses and cerebral microhemorrhages in vivo
por: Zhang, Hai, et al.
Publicado: (2023)

Association between alcohol and Alzheimer's disease
por: Huang, Wen-Juan, et al.
Publicado: (2016)

Chronic kidney disease promotes cerebral microhemorrhage formation
por: Fang, Chuo, et al.
Publicado: (2023)

Population attributable fraction of modifiable risk factors for Alzheimer disease: A systematic review of systematic reviews
por: Hazar, Narjes, et al.
Publicado: (2016)

Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review
por: Chui, Helena C, et al.
Publicado: (2012)

Aging exacerbates development of cerebral microbleeds in a mouse model
por: Sumbria, Rachita K., et al.
Publicado: (2018)

Disease-Modifying Activity of Huperzine A on Alzheimer’s Disease: Evidence from Preclinical Studies on Rodent Models
por: Yan, Ye-Piao, et al.
Publicado: (2022)

Vascular risk factors and Alzheimer’s disease
por: O’Brien, John T, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3nau1ho88p97i30gnnpea565di